Anti-Aging Drugs Market Trends

  • Report ID: 375
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Anti-Aging Drugs Market Trends

Growth Drivers

  • Growing Prevalence of Photoaging Among People - premature aging of the skin is caused by sun exposure. Skin damage caused by the sun is referred to by a number of names in dermatology, including photoaging. Certainly, UV exposure causes more visible signs of facial aging. Thus, the rising cases of photoaging are expected to propel the demand for anti-aging drugs during the forecast period. It was observed that, approximately 90% of European and North American adults with skin phototypes I, II, and III show clinically detectable photoaging.
  • An Increasing Number of Dermatologists - for instance, nearly 3,700 dermatologists are presently employed in the United States. Women account for over 85% of dermatologists, while men account for 14%.
  • Rising Personal Disposable Income - according to the Bureau of Economic Analysis, in July 2022 disposable personal income (DPI) increased by USD 37.6 billion (0.2%) in United States.
  • Increasing Level of Chronic Stress Among People- it was observed that globally, approximately 33% of people admitted feeling stressed.
  • Excessive Alcohol Consumption – according to the Centers for Diseases Control and Prevention, nearly 16% of adults are excessive alcohol drinkers, and 6% are reported, as heavy drinkers.

Challenges

  • High Cost of Anti-Aging Drugs - medical research and funding is vital and central for the development of aging-related medications. With huge funds invested in the scientific research and development of these drugs, it is still unaffordable for many.
  • Low Awareness of Anti-Aging Drugs in Low-Income Countries
  • Presence of Alternatives in the Market

Anti-Aging Drugs Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

10.3%

Base Year Market Size (2024)

USD 59.75 billion

Forecast Year Market Size (2037)

USD 215.95 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 375
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of anti-aging drugs is assessed at USD 64.72 billion.

The anti-aging drugs market size was valued at USD 59.75 billion in 2024 and is anticipated to reach USD 215.95 billion by the end of 2037, expanding at around 10.3% CAGR during the forecast period i.e., between 2025-2037. Rising adoption of anti aging products, desire to look young and healthy among elderly people along with increasing disposable income will boost the market growth.

North America is projected to dominate majority industry share by 2037, driven by increasing number of non-invasive cosmetic treatments, the growing demand for anti-aging products, and rapid expansion of the personal care industry.

The major players in the market include L’Oreal SA, Merz Pharma GmbH & Co., Novartis AG, BioTime Inc., ARK Skincare, Elysium Health Inc., Estee Lauder Inc., DermaFix, Bayer Pharma AG, La Roche-Posay.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample